Cart
sales@molnova.com
MG-115
CAS No. 133407-86-0
MG-115( —— )
Catalog No. M33748 CAS No. 133407-86-0
MG-115 (Z-LL-Nva-CHO) is a potent and reversible inhibitor of proteasome , with K i s of 21 nM and 35 nM for 20S and 26S proteasome, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 67 | Get Quote |
|
| 5MG | 93 | Get Quote |
|
| 10MG | 170 | Get Quote |
|
| 25MG | 302 | Get Quote |
|
| 50MG | 449 | Get Quote |
|
| 100MG | 642 | Get Quote |
|
| 200MG | 888 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMG-115
-
NoteResearch use only, not for human use.
-
Brief DescriptionMG-115 (Z-LL-Nva-CHO) is a potent and reversible inhibitor of proteasome , with K i s of 21 nM and 35 nM for 20S and 26S proteasome, respectively.
-
DescriptionMG-115 is a potent and reversible proteasome inhibitor, with Kis of 21 nM and 35 nM for 20S and 26S proteasome, respectively. MG-115 specifically inhibit the chymotrypsin-like activity of the proteasome, induces p53-dependent apoptosis.
-
In VitroMG-115 (0.1-10 μM; 24 h) dose-dependently decreases the viability of HepG2 cells.MG-115 (0.1-10 μM; 24 h) amplifies the reporter gene expression mediated by CWK18 DNA condensates.Cell Viability Assay Cell Line:HepG2 cells Concentration:0.1, 1, 2, 5, 10 μM Incubation Time:24 hoursResult:Dose-dependently decreased cell viability.Inhibited the proteasomal activity, with an IC50 of 2?μM.
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetProteasome
-
RecptorProteasome
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133407-86-0
-
Formula Weight461.59
-
Molecular FormulaC25H39N3O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (216.64 mM; Ultrasonic (<60°C)
-
SMILESCCCC(NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1)C=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rock KL, et, al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994 Sep 9;78(5):761-71.?
molnova catalog
related products
-
Oprozomib
Oprozomib (ONX-0912;PR-047) is a potent, orally bioavailable proteasome inhibitor that inhibits chymotrypsin-like (CT-L) activity of 20S proteasome β5/LMP7 with IC50 of 36/82 nM.
-
(R)-MG-132
(R)-MG-132 is the enantiomer of MG-132. (R)-MG-132 stereoisomer is a more potent proteasome inhibitor than MG-132. (R)-MG-132 is studied as a potential chymotrypsin-like inhibitor, trypsin-like, and peptidylglutamyl peptide hydrolyzing activities of proteasome.
-
MLN2238
A potent, selective, orally bioavailable proteasome inhibitor with IC50 of 3.4 nM.
